Borders TF, Booth BM. Rural, suburban, and urban variations in alcohol consumption in the United States: findings from the national epidemiologic survey on alcohol and related conditions. J Rural Health. 2007;23(4):314–21.
Friesen EL, Bailey J, Hyett S, Sedighi S, de Snoo ML, Williams K, et al. Hazardous alcohol use and alcohol-related harm in rural and remote communities: a scoping review. Lancet Pub Health. 2022;7(2):e177–87.
Jenkins RA. The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective. Prev Med. 2021;152:106541.
Jenkins RA, Whitney BM, Nance RM, Allen TM, Cooper HLF, Feinberg J, et al. The rural opioid initiative consortium description: providing evidence to understand the fourth wave of the opioid crisis. Addict Sci Clin Pract. 2022;17(1):38.
Hedegaard HS, RS. Urban-rural differences in drug overdose death rates, 1999–2019. NCHS Data Brief No. 403. https://www.cdc.gov/nchs/products/databriefs/db403.htm.
Coughlin LN, Bonar EE, Bohnert KM, Jannausch M, Walton MA, Blow FC, et al. Changes in urban and rural cigarette smoking and cannabis use from 2007 to 2017 in adults in the United States. Drug Alcohol Depend. 2019;205:107699.
Moore JR, Chen Q, Choi NG. Cannabis use, use frequency, and use disorder in large metropolitan, small metropolitan, and nonmetropolitan areas. Drug Alcohol Depend. 2021;221:108631.
Palombi LC, St Hill CA, Lipsky MS, Swanoski MT, Lutfiyya MN. A scoping review of opioid misuse in the rural United States. Ann Epidemiol. 2018;28(9):641–52.
Prunuske JP, St Hill CA, Hager KD, Lemieux AM, Swanoski MT, Anderson GW, et al. Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data. BMC Health Serv Res. 2014;14(1):563.
Jenkins RA, Hagan H. What is a rural opioid risk and policy environment? Int J Drug Policy. 2020;85:102606.
Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005;95(7):1149–55.
US Preventive Services Task Force. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: us preventive services task force recommendation statement. JAMA. 2018;320(18):1899–909.
US Preventive Services Task Force. Screening for unhealthy drug use: us preventive services task force recommendation statement. JAMA. 2020;323(22):2301–9.
Hallgren KA, Witwer E, West I, Baldwin LM, Donovan D, Stuvek B, et al. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. J Subst Abuse Treat. 2020;110:18–27.
D’Amico EJ, Paddock SM, Burnam A, Kung FY. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care. 2005;43(3):229–36.
McKnight-Eily LR, Okoro CA, Mejia R, Denny CH, Higgins-Biddle J, Hungerford D, et al. screening for excessive alcohol use and brief counseling of adults—17 states and the district of Columbia, 2014. MMWR Morb Mortal Wkly Rep. 2017;66(12):313–9.
Denny CH, Hungerford DW, McKnight-Eily LR, Green PP, Dang EP, Cannon MJ, et al. Self-reported prevalence of alcohol screening among U.S. adults. Am J Prev Med. 2016;50(3):380–3.
Venner KL, Sánchez V, Garcia J, Williams RL, Sussman AL. Moving away from the tip of the pyramid: screening and brief intervention for risky alcohol and opioid use in underserved patients. J Am Board Fam Med. 2018;31(2):243–51.
McNeely J, Adam A, Rotrosen J, Wakeman SE, Wilens TE, Kannry J, et al. Comparison of methods for alcohol and drug screening in primary care clinics. JAMA Netw Open. 2021;4(5):e2110721-e.
Garcia MC, Faul M, Massetti G, Thomas CC, Hong Y, Bauer UE, et al. Reducing potentially excess deaths from the five leading causes of death in the rural United States. MMWR Surveill Summ. 2017;66(2):1–7.
North Carolina Rural Health Research Program. Rural Health Snapshot 2017. https://www.shepscenter.unc.edu/wp-content/uploads/dlm_uploads/2017/05/Snapshot2017.pdf. Accessed 25 Nov 2022.
Saunders EC, Moore SK, Gardner T, Farkas S, Marsch LA, McLeman B, et al. Screening for substance use in rural primary care: a qualitative study of providers and patients. J Gen Intern Med. 2019;34(12):2824–32.
McNeely J, Kumar P, Rieckmann T, Sedlander E, Farkas S, Kannry J, et al. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff. Addict Sci Clin Pract 2018;13(1):8.
Moore SK, Saunders EC, Hichborn E, McLeman B, Meier A, Young R, et al. Early implementation of screening for substance use in rural primary care: a rapid analytic qualitative study. Subst Abus. 2021;42(4):678–91.
Chang CH, PWB J, Lurie JD. Geographic expansion of federally qualified health centers 2007–2014. J Rural Health. 2019;35(3):385–94.
Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26(1):13–24.
Kastner M, Straus SE. Application of the knowledge-to-action and medical research council frameworks in the development of an osteoporosis clinical decision support tool. J Clin Epidemiol. 2012;65(11):1163–70. https://doi.org/10.1016/j.jclinepi.2012.04.011.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 standards for quality improvement reporting excellence: revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986–92.
Seale JP, Shellenberger S, Velasquez MM, Boltri JM, Okosun I, Guyinn M, et al. Impact of vital signs screening & clinician prompting on alcohol and tobacco screening and intervention rates: a pre-post intervention comparison. BMC Fam Pract. 2010;11:18.
Lapham GT, Achtmeyer CE, Williams EC, Hawkins EJ, Kivlahan DR, Bradley KA. Increased documented brief alcohol interventions with a performance measure and electronic decision support. Med Care. 2012;50(2):179–87. https://doi.org/10.1097/MLR.0b013e3181e35743.
Saitz R, Horton NJ, Sullivan LM, Moskowitz MA, Samet JH. Addressing alcohol problems in primary care: a cluster randomized, controlled trial of a systems intervention. the screening and intervention in primary care (SIP) study. Ann Intern Med. 2003;138(5):372–82.
Ornstein SM, Miller PM, Wessell AM, Jenkins RG, Nemeth LS, Nietert PJ. Integration and sustainability of alcohol screening, brief intervention, and pharmacotherapy in primary care settings. J Stud Alcohol Drugs. 2013;74(4):598–604.
McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, et al. Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Ann Int Med. 2016;165:690.
NIDA CTN Common Data Elements. http://cde.drugabuse.gov/.
National Institute on Drug Abuse. Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool. https://nida.nih.gov/taps2/. Accessed 25 Nov 2022.
Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci. 2015;10(1):21. https://www.mypatientlink.com/
Shortell SM, Marsteller JA, Lin M, Pearson ML, Wu SY, Mendel P, et al. The role of perceived team effectiveness in improving chronic illness care. Med Care. 2004;42(11):1040–8.
Baskerville NB, Liddy C, Hogg W. Systematic review and meta-analysis of practice facilitation within primary care settings. Ann Fam Med. 2012;10(1):63–74.
Siantz E, Redline B, Henwood B. Practice facilitation in Integrated behavioral health and primary care settings: a scoping review. J Behav Health Serv Res. 2020;48:133.
Wang A, Pollack T, Kadziel LA, Ross SM, McHugh M, Jordan N, et al. Impact of practice facilitation in primary care on chronic disease care processes and outcomes: a systematic review. J Gen Intern Med. 2018;33(11):1968–77.
Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J Prim Care Commun Health. 2013;4(4):251–5.
Lapham GT, Lee AK, Caldeiro RM, Glass JE, Carrell DS, Richards JE, et al. Prevalence of behavioral health conditions across frequency of cannabis use among adult primary care patients in Washington State. J Gen Intern Med. 2018;33(11):1833–5.
Bradley KA, Lapham GT, Lee AK. Screening for drug use in primary care: practical implications of the new USPSTF recommendation. JAMA Int Med. 2020;180:1050.
Matson TE, Lapham GT, Bobb JF, Oliver M, Hallgren KA, Williams EC, et al. Validity of the single-Item screen-cannabis (SIS-C) for cannabis use disorder screening in routine care. JAMA Netw Open. 2022;5(11):e2239772.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 national survey on DRUG use and health rockville. MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020.
Tourangeau R, Smith TW. Asking sensitive questions—the impact of data collection mode, question format, and question context. Public Opin Quart. 1996;60(2):275–304.
Wight RG, Rotheram-Borus MJ, Klosinski L, Ramos B, Calabro M, Smith R. Screening for transmission behaviors among HIV-infected adults. Aids Educ Prev. 2000;12(5):431–41.
Adam A, Schwartz RP, Wu LT, Subramaniam G, Laska E, Sharma G, et al. Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool. Addict Sci Clin Pract. 2019;14(1):39.
Bright TJ, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux RR, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157(1):29–43.
Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223–38.
Anderson P, Wojnar M, Jakubczyk A, Gual A, Segura L, Sovinova H, et al. Managing alcohol problems in general practice in Europe: results from the European ODHIN survey of general practitioners. Alcohol Alcohol. 2014;49(5):531–9. https://doi.org/10.1093/alcalc/agu043. (Epub 2014 Jul 16).
Sterling S, Kline-Simon AH, Wibbelsman C, Wong A, Weisner C. Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012;7(1):13.
Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med care. 2001;39(8):II2–45.
Smith WR. Evidence for the effectiveness of techniques To change physician behavior. Chest. 2000;118(2 Supplement):8S-17S.
Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012;10:Cd006525.
Rombouts SA, Conigrave JH, Saitz R, Louie E, Haber P, Morley KC. Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: a systematic review. BMC Fam Pract. 2020;21(1):260.
Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425–31.
Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, et al. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015;10(1):26.
van Beurden I, Anderson P, Akkermans RP, Grol RP, Wensing M, Laurant MG. Involvement of general practitioners in managing alcohol problems: a randomized controlled trial of a tailored improvement programme. Addiction. 2012;107(9):1601–11.
Williams EC, Achtmeyer CE, Young JP, Rittmueller SE, Ludman EJ, Lapham GT, et al. Local Implementation of alcohol screening and brief intervention at five veterans health administration primary care clinics: perspectives of clinical and administrative staff. J Subst Abuse Treat. 2016;60:27–35.
Sayre M, Lapham GT, Lee AK, Oliver M, Bobb JF, Caldeiro RM, et al. Routine assessment of symptoms of substance use disorders in primary care: prevalence and severity of reported symptoms. J Gen Intern Med. 2020;35(4):1111–9.
HEDIS Measure: Unhealthy Alcohol Use Screening and Follow-Up. https://www.ncqa.org/hedis/reports-and-research/hedis-measure-unhealthy-alcohol-use-screening-and-follow-up/. Accessed 25 Nov 2022.
Czeisler M, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–57.
D’Onofrio G, P MV, Degutis LC, Fiellin DA, O’Connor P. The Yale Brief negotiated interview manual. New Haven, CT: Yale University School of Medicine. 2005.